327 related articles for article (PubMed ID: 37046686)
1. Diagnosis, Prognosis, and Treatment of Canine Hemangiosarcoma: A Review Based on a Consensus Organized by the Brazilian Association of Veterinary Oncology, ABROVET.
De Nardi AB; de Oliveira Massoco Salles Gomes C; Fonseca-Alves CE; de Paiva FN; Linhares LCM; Carra GJU; Dos Santos Horta R; Ruiz Sueiro FA; Jark PC; Nishiya AT; de Carvalho Vasconcellos CH; Ubukata R; Batschinski K; Sobral RA; Fernandes SC; Biondi LR; De Francisco Strefezzi R; Matera JM; Rangel MMM; Dos Anjos DS; Brunner CHM; Laufer-Amorim R; Cadrobbi KG; Cirillo JV; Martins MC; de Paula Reis Filho N; Silva Lessa DF; Portela R; Scarpa Carneiro C; Ricci Lucas SR; Fukumasu H; Feliciano MAR; Gomes Quitzan J; Dagli MLZ
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046686
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
[TBL] [Abstract][Full Text] [Related]
3. Canine and feline haemangiosarcoma.
Griffin MA; Culp WTN; Rebhun RB
Vet Rec; 2021 Nov; 189(9):e585. PubMed ID: 34213807
[TBL] [Abstract][Full Text] [Related]
4. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
[TBL] [Abstract][Full Text] [Related]
6. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas.
Hargis AM; Ihrke PJ; Spangler WL; Stannard AA
Vet Pathol; 1992 Jul; 29(4):316-28. PubMed ID: 1514218
[TBL] [Abstract][Full Text] [Related]
7. Molecular prevalence of Bartonella, Babesia, and hemotropic Mycoplasma species in dogs with hemangiosarcoma from across the United States.
Lashnits E; Neupane P; Bradley JM; Richardson T; Thomas R; Linder KE; Breen M; Maggi RG; Breitschwerdt EB
PLoS One; 2020; 15(1):e0227234. PubMed ID: 31923195
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
Burton JH; Powers BE; Biller BJ
Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy for cutaneous hemangiosarcoma in dogs.
Rocha MST; Lucci CM; Dos Santos JAM; Longo JPF; Muehlmann LA; Azevedo RB
Photodiagnosis Photodyn Ther; 2019 Sep; 27():39-43. PubMed ID: 31125768
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.
de Nardi AB; Dos Santos Horta R; Fonseca-Alves CE; de Paiva FN; Linhares LCM; Firmo BF; Ruiz Sueiro FA; de Oliveira KD; Lourenço SV; De Francisco Strefezzi R; Brunner CHM; Rangel MMM; Jark PC; Castro JLC; Ubukata R; Batschinski K; Sobral RA; da Cruz NO; Nishiya AT; Fernandes SC; Dos Santos Cunha SC; Gerardi DG; Challoub GSG; Biondi LR; Laufer-Amorim R; de Oliveira Paes PR; Lavalle GE; Huppes RR; Grandi F; de Carvalho Vasconcellos CH; Dos Anjos DS; Luzo ÂCM; Matera JM; Vozdova M; Dagli MLZ
Cells; 2022 Feb; 11(4):. PubMed ID: 35203268
[TBL] [Abstract][Full Text] [Related]
11. Comparative aspects and clinical outcomes of canine renal hemangiosarcoma.
Locke JE; Barber LG
J Vet Intern Med; 2006; 20(4):962-7. PubMed ID: 16955823
[TBL] [Abstract][Full Text] [Related]
12. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
[TBL] [Abstract][Full Text] [Related]
13. Primary Hemangiosarcoma of the Falciform Fat in Seven Dogs (2007-2015).
Mendez SE; Sykes Crumplar SE; Durham AC
J Am Anim Hosp Assoc; 2020; 56(2):120-126. PubMed ID: 31961215
[No Abstract] [Full Text] [Related]
14. Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma.
Musser ML; Coto GM; Lingnan Y; Mochel JP; Johannes CM
PLoS One; 2022; 17(12):e0279594. PubMed ID: 36548371
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
[TBL] [Abstract][Full Text] [Related]
16. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
[TBL] [Abstract][Full Text] [Related]
17. Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma.
Treggiari E; Borrego JF; Gramer I; Valenti P; Harper A; Finotello R; Toni C; Laomedonte P; Romanelli G
Vet Comp Oncol; 2020 Mar; 18(1):43-51. PubMed ID: 31648405
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
[TBL] [Abstract][Full Text] [Related]
19. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
